A multivariate study of protective effects of Zn and Cu against nephrotoxicity induced by cadmium metallothionein in rats.
Factorial experimental design was used to study the protective effects of Zn and Cu on cadmium-metallothionein(CdMT)-induced nephrotoxicity in male Wistar rats. In the factorial design two levels of Zn (0 and 25 mg/kg body weight), two levels of Cu (0 and 12.5 mg/kg), and two levels of CdMT (0.1 and 0.4 mg of Cd/kg) were used as varied factors. The factorial design was complemented with a center point with all three variables at an intermediate setting, i.e., Zn at 12.5 mg/kg, Cu at 6.25 mg/kg, and CdMT at 0.25 mg Cd/kg. Each of the nine combinations of settings was administered to one of nine groups with six rats in each. Zn and Cu were injected sc 24 hr prior to the injection of CdMT. The concentrations of protein and Ca in urine and Ca in renal cortex were used as effects. The relationship between the experimental design settings and the effects were modeled with multiple regression. The multiple regression analysis revealed that for the high dose of CdMT (i) the enhanced values of protein in urine caused by CdMT injection could be more efficiently reduced by Zn than by Cu, and (ii) excessive Ca in urine and renal cortex could be more efficiently reduced by Cu than by Zn. No significant synergism or antagonism between Cu and Zn was found. These models can be used to estimate the dose levels of Zn and Cu which will reduce the toxic effects of CdMT. The treatment of 20.4 mg/kg Zn, for example, will reduce the effects of 0.4 mg Cd/kg as CdMT on protein in urine, and 2.8 mg/kg Cu will reduce the Ca in urine to the levels of those caused by 0.25 mg Cd/kg (no Zn and Cu). Similarly, the effect of 0.4 mg Cd/kg on Ca level in renal cortex can be reduced to that of 0.28 mg Cd/kg as CdMT by 7.98 mg Cu/kg, which is three times as efficient as Zn. The obtained results might be of importance in understanding the mechanism of cadmium toxicity and the potential risk to the health of the population exposed to cadmium occupationally or environmentally.
Liu
X Y
XY
Department of Environmental Medicine, Umeå University, Sweden.
Jin
T Y
TY
Nordberg
G F
GF
Rännar
S
S
Sjöström
M
M
Zhou
Y
Y
D000818:Animals; D002104:Cadmium / Q000032:analysis; D002118:Calcium / Q000032:analysis / Q000652:urine; D003300:Copper / Q000627:therapeutic use*; D007672:Kidney Cortex / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D007674:Kidney Diseases / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D008297:Male; D008432:Mathematical Computing; D008668:Metallothionein / Q000032:analysis / Q000633:toxicity*; D008954:Models, Biological; D015999:Multivariate Analysis; D011507:Proteinuria / Q000139:chemically induced; D051381:Rats; D011919:Rats, Inbred Strains; D012044:Regression Analysis; D015032:Zinc / Q000627:therapeutic use*
C004203:cadmium-binding protein; D002104:Cadmium; D003300:Copper; D008668:Metallothionein; D015032:Zinc; D002118:Calcium